← Back to Search

Behavioral Intervention

Empowered Relief Class for Chronic Pain (ER-Y Trial)

N/A
Recruiting
Led By Laura Simons, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Chronic Pain
Age at least 10 years old to 18 years
Must not have
Diagnosis of neurological conditions such as seizures, cerebral palsy, developmental delay
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately post class
Awards & highlights

Summary

This trial is testing a single-session pain management class to help youth manage their chronic pain. Feasibility and acceptability will be assessed, and its efficacy tracked over 12 weeks.

Who is the study for?
This trial is for English-speaking youths aged 10 to 18 who have been diagnosed with various types of chronic pain, including neuropathic pain and fibromyalgia. It's not suitable for those with neurological conditions like seizures or severe mental health issues such as intense depression or anxiety.
What is being tested?
The study tests a single-session class called Empowered Relief for Youth (ER-Y), which educates about pain science and teaches self-regulation skills for managing chronic pain. The program's feasibility and effectiveness will be evaluated over a period of up to 12 weeks post-class.
What are the potential side effects?
Since ER-Y involves educational classes rather than medication, traditional side effects are not expected. However, participants may experience varying degrees of emotional discomfort when discussing their experiences with chronic pain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with chronic pain.
Select...
I am between 10 and 18 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with a neurological condition like seizures or cerebral palsy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks, 8 weeks, and 12 weeks post class
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks, 8 weeks, and 12 weeks post class for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Program Feedback Scale
Treatment Expectancy Credibility (TEC-C)
Secondary study objectives
PROMIS Pain Interference
Pain Catastrophizing Scale (PCS)
Patient Global Impression of Change (PGIC)
Other study objectives
Child Pain Self-Efficacy Scale (PSES-C)
Hope Scale
PROMIS Anxiety
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Empowered Relief for YouthExperimental Treatment1 Intervention
Empowered Relief for Youth is a single-session pain management class focused on pain science education and teaching self-regulatory skills for pain management based on the evidence-based adult ER class.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,448 Previous Clinical Trials
17,492,334 Total Patients Enrolled
Laura Simons, PhDPrincipal InvestigatorStanford University
3 Previous Clinical Trials
127 Total Patients Enrolled

Media Library

Empowered Relief for Youth (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05998369 — N/A
Complex Regional Pain Syndrome Research Study Groups: Empowered Relief for Youth
Complex Regional Pain Syndrome Clinical Trial 2023: Empowered Relief for Youth Highlights & Side Effects. Trial Name: NCT05998369 — N/A
Empowered Relief for Youth (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05998369 — N/A
~26 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top